VideoViral Hepatitis and Liver DiseaseHIVClinical Care Pathways for the Risk Stratification of Patients - Emmanuel Tsochatzis, MD, MSc, FEBTM, FRCP, PhDView Video
VideoViral Hepatitis and Liver DiseaseUse of Intelligent Liver Function Testing in General Practice - John Dillon MB,BS,MD,MRCP(UK),FRCP(Edinburgh) videoView Video
VideoViral Hepatitis and Liver DiseasePushing for Weight Management: Bariatric Interventions Benefits and Considerations - Jörn Schattenberg, MD videoView Video
VideoViral Hepatitis and Liver DiseaseHow to Use Diabetes Drugs for Liver Benefit in Patients with NAFLD - Kenneth Cusi, MD, FACP, FACE videoView Video
VideoViral Hepatitis and Liver DiseaseIntegrating Non-Invasive Tests for NAFLD in Clinical Practice Outside the Liver Space - Which Test and at What Level? - Alina Allen, MD videoView Video
VideoViral Hepatitis and Liver DiseaseThe Road to Comprehensive Models of Care for NAFLD - What Are the Endpoints? - Jeffrey Lazarus, PhD, MIH, MA videoView Video
VideoViral Hepatitis and Liver DiseaseUsing the Power of Digital Innovation - Apps Transforming Weight Management - Marcus Ranney, MD VIDEOView Video
VideoViral Hepatitis and Liver DiseaseThe Central Role of Primary Care in the NASH Epidemic: Opportunities and Challenges - Helen Jarvis, MD VideoView Video
VideoViral Hepatitis and Liver DiseaseWhy and How to Identify NAFLD in Primary Care? - Jean Muris, MD PhD videoView Video
VideoViral Hepatitis and Liver DiseasePharmacotherapy for Obesity - Improving Body Weight and NAFLD - Naim Alkhouri, MD videoView Video
VideoViral Hepatitis and Liver DiseaseLiver-Directed Drugs in the Pipeline for Fibrotic NASH - Stephen Harrison, M.D, FACP, FAASLD Col (ret.) videoView Video
VideoViral Hepatitis and Liver DiseaseFatal Triple – Linking Obesity, Type-2 Diabetes, and NASH - Cyrielle Caussy, MD, PhD videoView Video
VideoViral Hepatitis and Liver DiseaseIs NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD videoView Video
VideoViral Hepatitis and Liver DiseaseThe Liver-Heart Axis – Does NASH Drive Cardiovascular Disease? - Sven Francque, MD, PhD videoView Video
VideoViral Hepatitis and Liver DiseaseExchanging and Sharing Ideas on the NAFLD/NASH Roadmap Including Social Media and Digital Transformation of Health Care - Roundtable discussion Session 6View Video
VideoViral Hepatitis and Liver DiseaseRoundtable Discussion: the NAFLD Continuum of Care - Patient Organization SessionView Video
VideoViral Hepatitis and Liver DiseaseRoundtable Discussion: Industry Developments Advancing Comprehensive Care Models for NAFLDView Video
